| Literature DB >> 32718123 |
Özgür Tanrıverdi1, Ahmet Ozan Çetin2, Ali Alkan1.
Abstract
Background/aim: The aim of this study was to determine whether breast surgery changes body posture in patients with early-stage breast cancer. Materials and methods: Study variables include age, side and localization of the tumor in the breast, applied breast surgery, axillary interference, pathological tumor size, axillary lymph node metastasis, body mass index, bone density, adjuvant therapies, and histological type. Thoracic kyphosis angle due to the anatomically affected primary region to detect changes in body posture and Cobb’s method were used to measure this.Entities:
Keywords: Breast cancer; body posture; thoracic kyphosis; Cobb’s angle
Year: 2021 PMID: 32718123 PMCID: PMC8203123 DOI: 10.3906/sag-1912-22
Source DB: PubMed Journal: Turk J Med Sci ISSN: 1300-0144 Impact factor: 0.973
Demographic and clinical features of patients.
| Features | Findings |
|---|---|
| Age (years); mean ± standard deviation | 55.6 ± 12.5 |
| Body mass index (kg/m2); n (%) | |
| Normal weight | 3 (5) |
| Overweight | 48 (84) |
| Class 1 obesity | 6 (11) |
| DEXA; n (%) | |
| Normal | 13 (28) |
| Osteopenia | 32 (68) |
| Osteoporosis | 2 (4) |
| Type of surgery; n (%) | |
| BCS | 8 (14) |
| MRM | 49 (86) |
| Axillary surgery; n (%) | |
| Sentinel lymph node biopsy | 4 (7) |
| Axillary dissection | 53 (93) |
| Pathologic tumor size (mm); mean ± standard deviation | 24.5 ± 2.7 |
| Number of dissected lymph node; average (range) | 15 (1-33) |
| Number of metastatic lymph node; average (range) | 6 (0-23) |
| Basal cobb angle (°); mean ± standard deviation | 33.6 ± 3.0 |
| Follow-up time (months); average (range) | 43.6 (22.8-65.4) |
| Localization; n (%) | |
| Right breast | 27 (47) |
| Left breast | 30 (53) |
| Localization in the breast; n (%) | |
| Upper outer quadrant | 29 (51) |
| Upper inner quadrant | 8 (14) |
| Lower outer quadrant | 8 (14) |
| Lower inner quadrant | 5 (9) |
| Areolar | 6 (10) |
| Multifocal | 1 (2) |
| Histological type; n (%) | |
| Invasive ductal carcinoma | 52 (91) |
| Invasive lobular carcinoma | 3 (5) |
| Tubular carcinoma | 1 (2) |
| Infiltrating carcinoma | 1 (2) |
| Axillary involvement; n (%) | |
| Present | 27 (47) |
| Absent | 30 (53) |
| Adjuvant chemotherapy; n (%) | 49 (86) |
| Adjuvant radiotherapy; n (%) | 37 (65) |
| Neoadjuvant chemotherapy; n (%) | 10 (17) |
| Adjuvant endocrine treatment; n (%) | |
| Tamoxifen | 7 (12) |
| Letrozole | 14 (26) |
| Anastrozole | 27 (47) |
| Absent | 9 (15) |
DEXA: dual energy X-ray absorptiometry; BCS: breast-conserving surgery; MRM: modified radical mastectomy.
Correlation coefficients between the changes in Cobb’s angle at the end of 2nd year according to the basal in cases followed for 2 years and other demographic-clinical features of the cases.
| Correlation coefficient | P-value † | |
|---|---|---|
| Age | 0.616 | <0.001 |
| Weight | 0.028 | 0.838 |
| Basal BMI | 0.158 | 0.240 |
| Follow-up time | -0.241 | 0.071 |
| Tumor size | -0.040 | 0.772 |
| Change in BMI | 0.529 | <0.001 |
| Adjuvant radiotherapy | 0.179 | 0.205 |
| Axillary dissection | 0.304 | 0.118 |
† Spearman’s rank-order correlation test. BMI: body mass index.
The factors associated with increase in Cobb’s angle.
| n | Increase inCobb angle | P | |
|---|---|---|---|
| DEXA | |||
| Normal | 13 | 2.08 ± 2.10 | |
| Osteopenia/Osteoporosis | 34 | 2.91 ± 2.54 | 0.298 |
| Type of surgery | |||
| BCS | 8 | 4.12 ± 2.70 | |
| MRM | 49 | 2.35 ± 2.24 | 0.048 |
| Adjuvant radiation treatment | |||
| Present | 37 | 2.36 ± 1.31 | |
| Absent | 20 | 2.04 ± 1.24 | 0.274 |
| Axillary dissection | |||
| Present | 53 | 2.14 ± 1,11 | |
| Absent | 4 | 2.04 ± 1.06 | 0.138 |
| Localization | |||
| Right | 27 | 2.85 ± 2.73 | |
| Left | 30 | 2.37 ± 2.01 | 0.445 |
| General | 57 | 2.60 ± 2.37 | - |
Data are shown as average ± standard deviation,† Student’s t-test. DEXA: dual energy X-ray absorptiometry; BCS: breast-conserving surgery; MRM: modified radical mastectomy.
Multivariate analysis of factors associated with Cobb’s angle in years.
| Regressioncoefficient | %95 confidence interval | t-statistics | P-value | ||
|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||
| Model 1 a | |||||
| Diagnosis age | 0.072 | 0.031 | 0.113 | 3.528 | <0.001 |
| Monitoring times | –0.022 | –0.055 | 0.010 | –1.375 | 0.175 |
| Change in BMI | 0.632 | 0.280 | 0.985 | 3.598 | <0.001 |
| BCS | 1.105 | –0.146 | 2.356 | –1.773 | 0.082 |
| Model 2 b | |||||
| Diagnosis age | 0.094 | 0.034 | 0.154 | 3.188 | 0.003 |
| Pathologic tumor size | –0.020 | –0.063 | 0.023 | –0.927 | 0.361 |
| Change in BMI | 0.897 | 0.423 | 1.372 | 3.847 | <0.001 |
| Model 3 c | |||||
| Diagnosis age | 0.136 | 0.041 | 0.232 | 2.971 | 0.007 |
| Pathologic tumor size | –0.044 | –0.103 | 0.015 | –1.562 | 0.132 |
| Change in BMI | 0.940 | –0.146 | 2.027 | 1.794 | 0.087 |
| Model 4 d | |||||
| Diagnosis age | 0.320 | 0.187 | 0.454 | 5.433 | <0.001 |
| Change in BMI | –0.315 | –1.796 | 1.166 | –0.481 | 0.642 |
a: Analysis done in cases followed for 2 years, b: analysis done in cases followed for 3 years, c: Analysis done in cases followed for 4 years, d: Analysis done in cases followed for 5 years.BMI: body mass index; BCS: breast-conserving surgery.